Line 571: | Line 571: | ||
<br>• A temperature-sensitivity test was performed for cells with pSIM5, a temperature sensitive plasmid. An overnight culture was incubated at 37°C and a control was incubated at 28°C. The overnight culture at 37°C was tested as positive and lost the plasmid, while the control maintained its plasmid.</br> | <br>• A temperature-sensitivity test was performed for cells with pSIM5, a temperature sensitive plasmid. An overnight culture was incubated at 37°C and a control was incubated at 28°C. The overnight culture at 37°C was tested as positive and lost the plasmid, while the control maintained its plasmid.</br> | ||
<br>• Two clones of yeast cells carrying the Cas9 plasmid made competent for the next transformation</br> | <br>• Two clones of yeast cells carrying the Cas9 plasmid made competent for the next transformation</br> | ||
− | <br>• Sent for Sequencing: <a href="#BB2_19" class="bgscroll"> BB2_19</a>, <a href="#BB2_21" class="bgscroll"> BB2_21</a>, <a href="#BB2_31" class="bgscroll"> BB2_31</a>, <a href="#BB2_32" class="bgscroll"> BB2_32</a>, <a href="#BB2_33" class="bgscroll"> BB2_33</a>, <a href="#BB2_34" class="bgscroll"> BB2_34</a>, <a href="#BB3_01" class="bgscroll"> BB3_01</a>, <a href="#BB3_13" class="bgscroll"> BB3_13</a>, <a href="#BB3_14" class="bgscroll"> BB3_14</a>, C-PPP_02, C-PPP_03</br> | + | <br>• Sent for Sequencing: <a href="#BB2_19" class="bgscroll"> BB2_19</a>, <a href="#BB2_21" class="bgscroll"> BB2_21</a>, <a href="#BB2_31" class="bgscroll"> BB2_31</a>, <a href="#BB2_32" class="bgscroll"> BB2_32</a>, <a href="#BB2_33" class="bgscroll"> BB2_33</a>, <a href="#BB2_34" class="bgscroll"> BB2_34</a>, <a href="#BB3_01" class="bgscroll"> BB3_01</a> (unsuccessful), <a href="#BB3_13" class="bgscroll"> BB3_13</a>, <a href="#BB3_14" class="bgscroll"> BB3_14</a>, C-PPP_02, C-PPP_03</br> |
<div id="BB2_19" class="modalDialog "> | <div id="BB2_19" class="modalDialog "> | ||
Line 694: | Line 694: | ||
<br>• PCR: DH5-α pSIM5, #71, #72</br> | <br>• PCR: DH5-α pSIM5, #71, #72</br> | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification according to protocol. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification according to protocol. | ||
− | <br><br>• Golden Gate Assembly of <a href="#BB1_27" class="bgscroll"> BB1_27</a>, <a href="#BB3_01" class="bgscroll"> BB3_01</a>, <a href="#BB3_03" class="bgscroll"> BB3_03</a>, <a href="#BB3_30" class="bgscroll"> BB3_30</a>, <a href="#BB3_31" class="bgscroll"> BB3_31</a>, <a href="#BB3_32" class="bgscroll"> BB3_32</a>, <a href="#BB3_33" class="bgscroll"> BB3_33</a></br> | + | <br><br>• Golden Gate Assembly of <a href="#BB1_27" class="bgscroll"> BB1_27</a>, <a href="#BB3_01" class="bgscroll"> BB3_01</a> (unsuccessful), <a href="#BB3_03" class="bgscroll"> BB3_03</a>, <a href="#BB3_30" class="bgscroll"> BB3_30</a>, <a href="#BB3_31" class="bgscroll"> BB3_31</a>, <a href="#BB3_32" class="bgscroll"> BB3_32</a>, <a href="#BB3_33" class="bgscroll"> BB3_33</a></br> |
GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected out by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected out by using antibiotic-containing media. The next day, positives clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> | ||
<br>• <a href="#BB3_32" class="bgscroll"> BB3_32</a> cultivated in YP-G418, a yeast peptone media</br> | <br>• <a href="#BB3_32" class="bgscroll"> BB3_32</a> cultivated in YP-G418, a yeast peptone media</br> | ||
Line 734: | Line 734: | ||
Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification according to protocol. | Each PCR was loaded on a preparative gel and cut out before undergoing PCR-purification according to protocol. | ||
− | <br><br>•Golden Gate Assembly of <a href="#BB3_01" class="bgscroll">BB3_1</a>, C-PPP_08, C-PPP_09, <a href="#C-PPP_10" class="bgscroll">C-PPP_10</a>, <a href="#BB3_33" class="bgscroll">BB3_33</a>, <a href="#C-PPP_07" class="bgscroll">C-PPP_07</a></br> | + | <br><br>•Golden Gate Assembly of <a href="#BB3_01" class="bgscroll">BB3_1</a> (unsuccessful), C-PPP_08, C-PPP_09, <a href="#C-PPP_10" class="bgscroll">C-PPP_10</a>, <a href="#BB3_33" class="bgscroll">BB3_33</a>, <a href="#C-PPP_07" class="bgscroll">C-PPP_07</a></br> |
GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected out by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> | GG-products are then transformed into competent cells. Colonies with specific antibiotic resistances were selected out by using antibiotic-containing media. The next day, positive clones were confirmed via an OneTaq colony PCR and a gel electrophoresis before a Miniprep was made.</br> | ||
Revision as of 16:20, 31 October 2017
Notebook.
All protocols we used for the methods can be found here:
Protocol
For further information regarding our Golden Gate Assembly products, please refer to our part collection site.
Week 1 (03/07-07/07)
Week 2 (10/07-14/07)
Week 3 (17/07-21/07)
Week 4 (24/07-28/07)
Week 5 (31/07-04/08)
Week 6 (07/08-11/08)
Week 7 (14/08-18/08)
Week 8 (21/08-25/08)
Week 9 (28/08-01/09)
Week 10 (04/09-08/09)
Week 11 (11/09-15/09)
Week 12 (18/09-22/09)
Week 13 (25/09-29/09)
Week 14 (02/10-06/10)
Week 15 (09/10-13/10)